Stock MNPR MONOPAR THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Monopar Therapeutics Inc.

Equities

MNPR

US61023L1089

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.7117 USD -1.17% Intraday chart for Monopar Therapeutics Inc. -1.17% +109.20%
Jul. 09 Monopar Therapeutics Inc. Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr CI
May. 24 Monopar Therapeutics Names Karthik Radhakrishnan as CFO MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNPR Stock
  4. News Monopar Therapeutics Inc.
  5. MarketScreener Editorial Features